D.E. Shaw & Co
NNVC icon

D.E. Shaw & Co’s NanoViricides NNVC Stock Holding History

D.E. Shaw & Co’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,546
Closed -$36K – 3658
2015
Q4 		$36K Buy
1,546
+63
+4% +$1.51K ﹤0.01% 3732
2015
Q3 		$35K Sell
1,483
-970
-40% -$25.7K ﹤0.01% 3673
2015
Q2 		$85K Sell
2,453
-313
-11% -$11.9K ﹤0.01% 3663
2015
Q1 		$124K Buy
2,766
+1,416
+105% +$75.5K ﹤0.01% 3506
2014
Q4 		$73K Buy
+1,350
New +$89.4K ﹤0.01% 3923
2014
Q3 		– Sell
-523
Closed -$44K – 4295
2014
Q2 		$44K Buy
+523
New +$37.1K ﹤0.01% 4111

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

D.E. Shaw & Co's NNVC Position: Q1 2016 in Review

D.E. Shaw & Co sold out of NanoViricides (NNVC) in Q1 2016, closing a stake of 1,546 shares — an estimated $36K sold.

D.E. Shaw & Co first reported a position in NNVC in Q2 2014 and held it in 6 quarters. The position peaked at $124K in Q1 2015. 55 funds tracked by Wall St. Rank hold NNVC as of Q1 2016.

  • D.E. Shaw & Co reported no remaining NanoViricides position as of Q1 2016 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,546 NanoViricides shares in Q1 2016, an estimated $36K.
  • D.E. Shaw & Co first reported a position in NanoViricides in Q2 2014 and held it in 6 quarters.
  • D.E. Shaw & Co's NanoViricides position peaked at $124K in Q1 2015.
  • 55 funds tracked by Wall St. Rank held NanoViricides as of Q1 2016.

Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.